TACE with portal vein radioactive seeds for HCC with portal vein tumor thrombus: a meta-analysis

References

• Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153–159.
   PubMed Web of Science ®Google Scholar
• Sim HW, Knox J. Hepatocellular carcinoma in the era of immunotherapy. Curr Probl Cancer. 2018;42(1):40–48.
   PubMed Web of Science ®Google Scholar
• Pirisi M, Avellini C, Fabris C, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol. 1998;124(7):397–400.
   PubMedGoogle Scholar
• Zhang XB, Wang JH, Yan ZP, et al. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization. Cancer. 2009;115(6):1245–1252.
   PubMedGoogle Scholar
• Hu HT, Kim JH, Lee LS, et al. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol. 2011;22(7):917–923.
   PubMed Web of Science ®Google Scholar
• Katagiri S, Yamamoto M. Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surg Today. 2014;44(2):219–226.
   PubMed Web of Science ®Google Scholar
• Niu ZJ, Ma YL, Kang P, et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Med Oncol. 2012;29(4):2992–2997.
   PubMed Web of Science ®Google Scholar
• Xiang X, Lau WY, Wu ZY, et al. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus: a multicenter study. Eur J Surg Oncol. 2019;45(8):1460–1467.
   PubMed Web of Science ®Google Scholar
• Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 2008;7(3):237–257.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Hu HT, Luo JP, Li HL, et al. Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus. Oncotarget. 2017;8(17):29258–29268.
   PubMedGoogle Scholar
• Jiang L, Han DM, Hu HT, et al. The value of 125iodine implantation combining transcatheter arterial chemoembolization to prevent digestive tract bleeding in patients with portal vein tumor thrombus in primary hepatocellular carcinoma. Chin J Radiol. 2016;50:784–788.
   Google Scholar
• Chuan-Xing L, Xu H, Bao-Shan H, et al. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed. Cancer Biol Ther. 2011;12(10):865–871.
   PubMed Web of Science ®Google Scholar
• Luo JJ, Zhang ZH, Liu QX, et al. Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus. Hepatol Int. 2016;10(1):185–195.
   PubMed Web of Science ®Google Scholar
• Weng ZC, Yang WZ, Jiang N, et al. Evaluation of CT-guided 125I seed implantation combined with transcatheter arterial chemoembolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma. J Intervent Radiol. 2010;19:535–539.
   Google Scholar
• Wu LL, Luo JJ, Yan ZP, et al. [Comparative study of portal vein stent and TACE combined therapy with or without endovascular implantation of iodine-125 seeds strand for treating patients with hepatocellular carcinoma and main portal vein tumor thrombus]. Zhonghua Gan Zang Bing Za Zhi. 2012;20(12):915–919.
   PubMedGoogle Scholar
• Wu LL, Yan ZP, Zhang W, et al. Transcatheter arterial chemoembolization combined with endovascular 125I seed strip implantation for primary hepatocellular carcinoma associated with portal vein tumor thrombus: analysis of curative effect. J Intervent Radiol. 2015;24:776–780.
   Google Scholar
• Wu YF, Wang T, Yue ZD, et al. Stents combined with iodine-125 implantation to treat main portal vein tumor thrombus. WJGO. 2018;10(12):496–504.
   Google Scholar
• Zhou Y, Su HY, Hong D, et al. Efficacy and survival analysis of iodine-125 seed placement combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Chin J Cancer Prev Treat. 2018;25:1664–1669.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and Meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–W94.
   PubMed Web of Science ®Google Scholar
• Cook DA, Reed DA. Appraising the quality of medical education research methods: the medical education research study quality instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015;90(8):1067–1076.
   PubMed Web of Science ®Google Scholar
• Lalchandani UR, Sahai V, Hersberger K, et al. A radiologist's guide to response evaluation criteria in solid tumors. Curr Probl Diagn Radiol. 2019;48(6):576–585.
   PubMedGoogle Scholar
• Li Q, Wang J, Sun Y, et al. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis–a randomized study. World J Surg. 2006;30(11):2004–2013.
   PubMedGoogle Scholar
• Yoon SM, Lim YS, Won HJ, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys. 2012;82(5):2004–2011.
   PubMed Web of Science ®Google Scholar
• Zhu K, Chen J, Lai L, et al. Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib-a retrospective controlled study. Radiology. 2014;272(1):284–293.
   PubMedGoogle Scholar
• Yu TZ, Zhang W, Liu QX, et al. Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus. Oncotarget. 2017;8(7):12108–12119.
   PubMedGoogle Scholar
• Li S, Guo JH, Lu J, et al. I125 irradiation stent for treatment of hepatocellular carcinoma with portal vein thrombosis: a meta-analysis. Cancer Radiother. 2021;25(4):340–349.
   Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370.
   PubMed Web of Science ®Google Scholar